Fig. 3From: Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinomaIdentification of an immune signature predicting prognosis risk of patients in LUAD using model 4 (a survival analysis of the training dataset; b survival analysis in the testing data; c The heatmaps distinct gene expression profiles of the cases belonging to the high and low risk score groups)Back to article page